Clinical Trials Browser

INDUSTRY × Vomiting × Clear all

NCT06904235 2026-03-31

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Phase 2 Recruiting

Nausea, Vomiting

NCT07169851 2026-03-20

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Phase 2 Recruiting

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT00343460 2026-03-02

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Phase 3 Completed

1,428 enrolled 21 charts

Nausea, Vomiting

NCT01596413 2024-07-26

Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

Phase 1 Withdrawn

Vomiting

NCT01596426 2024-07-26

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Phase 1 Withdrawn

Vomiting

NCT03204279 2024-06-25

CINV

Phase 2 Completed

67 enrolled 12 charts

Vomiting

NCT01596400 2024-06-17

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Phase 1 Completed

Vomiting

NCT03649230 2023-08-18

EVOLVE_CINV

207 enrolled 10 charts

Vomiting

NCT05272865 2023-02-01

Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

Phase 1/2 Unknown

Cancer Pain, Neoplasms, Vomiting

NCT05199818 2023-01-20

Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

Phase 3 Unknown

Vomiting

NCT04430842 2023-01-18

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Phase 1 Completed

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Sleepiness, Mesothelioma, Malignant, Anorexia, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Headache, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Seizures, Speech Disorders, Stomach Neoplasms, Thymoma, Tongue Neoplasms, Urologic Neoplasms, Vomiting, Colorectal Neoplasms, Cholangiocarcinoma

NCT01363479 2021-09-22

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Phase 3 Completed

743 enrolled 10 charts

Vomiting

NCT00285051 2020-12-23

Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

Phase 2 Terminated

Nausea, Neoplasms, Vomiting

NCT03403712 2020-06-01

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Phase 3 Completed

404 enrolled 19 charts

Vomiting

NCT01636947 2018-09-25

KMEC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT02557035 2018-06-20

An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting

Phase 3 Completed

441 enrolled 20 charts

Vomiting

NCT00601172 2018-01-17

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Phase 3 Completed

710 enrolled 29 charts

Gastrointestinal

Nausea, Vomiting, Colorectal Neoplasms

NCT00334646 2017-11-17

Cyclophosphamide Drug Interaction Study In Cancer Patients

Phase 1 Terminated

Nausea, Vomiting

NCT00431236 2017-08-22

A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase 3 Completed

Nausea, Vomiting

NCT00440128 2017-08-04

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Phase 1 Completed

Nausea, Vomiting

NCT01366599 2017-05-24

CV Events in Emetogenic Chemotherapy

12,058 enrolled

Vomiting

NCT00684463 2017-05-16

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Phase 4 Completed

Nausea, Neoplasms, Vomiting

NCT00687011 2017-05-15

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

Phase 4 Completed

Nausea, Neoplasms, Vomiting

NCT00092183 2017-05-05

An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)

Phase 4 Completed

Breast Neoplasms, Nausea, Vomiting

NCT00092196 2017-05-05

Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)

Phase 3 Completed

Breast Neoplasms, Nausea, Vomiting

NCT01887314 2016-01-27

Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy

Phase NA Completed

Nausea, Neoplasms, Vomiting

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Phase 1 Completed

Nausea, Neoplasms, Vomiting

NCT00891761 2015-04-17

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase 3 Withdrawn

Lung Neoplasms, Nausea, Neoplasms, Vomiting

NCT01339260 2014-11-26

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Phase 3 Completed

1,455 enrolled 11 charts

Vomiting

NCT00212602 2012-06-14

ONO-7436 Phase II Study in Japan

Phase 2 Completed

Nausea, Neoplasms, Vomiting

NCT00169572 2010-05-10

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Phase 2 Completed

Nausea, Vomiting